Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Dakota Wealth Management

Dakota Wealth Management trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 3.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,105 shares of the company’s stock after selling 529 shares during the quarter. Dakota Wealth Management’s holdings in Henry Schein were worth $907,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. FMR LLC boosted its stake in shares of Henry Schein by 7.8% in the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP lifted its stake in Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after acquiring an additional 600,000 shares during the last quarter. Nuance Investments LLC grew its holdings in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC increased its position in shares of Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Henry Schein by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock valued at $85,662,000 after purchasing an additional 6,184 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on HSIC shares. Jefferies Financial Group increased their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.30.

Get Our Latest Stock Report on Henry Schein

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.14% of the stock is currently owned by insiders.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $74.97 on Friday. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The stock has a market capitalization of $9.35 billion, a price-to-earnings ratio of 30.85, a PEG ratio of 2.04 and a beta of 0.89. The company has a 50-day simple moving average of $72.99 and a 200-day simple moving average of $70.96. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same period last year, the firm earned $1.32 EPS. On average, analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.